Although these findings generally support the role of leptin as a promising MSC priming agent, they do not necessarily indicate a beneficial effect of leptin on MSC viability and function in pathological contexts, including obesity. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.